Q2 Report and CC scheduled for Aug. 11 after the close | RGLS Message Board Posts


Regulus Therapeutics Inc.

  RGLS website

RGLS   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  847 of 869  at  8/12/2022 12:00:46 PM  by

Steve_382


 In response to msg 846 by  Steve_382
view thread

Re: Q2 Report and CC scheduled for Aug. 11 after the close

 Well, it was a very brief CC and the only real positive I could get from it was this statement from Jay.
 
<<<<The single ascending dose study is nearing completion consistent with our planned execution and timelines and the multiple ascending dose portion of the study is well on track for initiation shortly after completion of the SAD study.>>>>
 
Perhaps that is all we can expect for now. At least it hasn't been stopped for safety issues. That and they still have enough cash into Q4 2023.


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 3  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board




Financial Market Data provided by
.
Loading...